Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$288.23 - $331.73 $6.31 Million - $7.26 Million
21,900 Added 190.43%
33,400 $10.5 Million
Q1 2024

May 15, 2024

BUY
$247.84 - $340.0 $693,952 - $952,000
2,800 Added 32.18%
11,500 $3.86 Million
Q4 2023

Feb 14, 2024

SELL
$222.83 - $285.76 $6.13 Million - $7.86 Million
-27,500 Reduced 75.97%
8,700 $2.46 Million
Q3 2023

Nov 14, 2023

BUY
$236.44 - $265.62 $1.51 Million - $1.7 Million
6,400 Added 21.48%
36,200 $8.91 Million
Q2 2023

Aug 14, 2023

SELL
$183.12 - $250.2 $2.36 Million - $3.23 Million
-12,900 Reduced 30.21%
29,800 $7.46 Million
Q1 2023

May 15, 2023

BUY
$193.59 - $245.33 $6.16 Million - $7.8 Million
31,800 Added 291.74%
42,700 $9.12 Million
Q4 2022

Feb 14, 2023

SELL
$173.9 - $224.8 $1.03 Million - $1.33 Million
-5,900 Reduced 35.12%
10,900 $2.12 Million
Q3 2022

Nov 14, 2022

SELL
$183.25 - $247.5 $714,675 - $965,250
-3,900 Reduced 18.84%
16,800 $3.09 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $24.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.